Haloperidol Injection
» Haloperidol Injection is a sterile solution of Haloperidol in Water for Injection, prepared with the aid of Lactic Acid. It may contain a suitable preservative. It contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C21H23ClFNO2.
Packaging and storage— Preserve in single-dose or in multiple-dose containers, preferably of Type I glass, protected from light.
Identification— The solution prepared for measurement of absorbance in the Assay exhibits a maximum at 245 ± 2 nm.
Bacterial endotoxins 85 It contains not more than 71.4 USP Endotoxin Units per mg of haloperidol.
pH 791: between 3.0 and 3.8.
Other requirements— It meets the requirements under Injections 1.
Assay— Transfer an accurately measured volume of Injection, equivalent to about 10 mg of haloperidol, to a separator, and add 20 mL of dilute hydrochloric acid (1 in 20). Extract the solution with four 25-mL portions of ether, and wash the combined ether extracts with four 5-mL portions of dilute hydrochloric acid (1 in 20). Proceed as directed in the Assay under Haloperidol Solution, beginning with “Discard the ether.” Calculate the quantity, in mg, of C21H23ClFNO2 in each mL of Injection taken by the formula:
0.5(C / V)(AU / AS)
in which C is the concentration, in µg per mL, of USP Haloperidol RS in the Standard solution; V is the volume, in mL, of Injection taken; and AU and AS are the absorbances of the solution from the Injection and the Standard solution, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ravi Ravichandran, Ph.D.
Senior Scientist
(MDPP05) Monograph Development-Psychiatrics and Psychoactives
Reference Standards Lili Wang, Technical Services Scientist
85 Radhakrishna S Tirumalai, Ph.D.
Senior Scientist
(MSA05) Microbiology and Sterility Assurance
USP32–NF27 Page 2548